SubbaRao V. Tulimilli

404 citations
12 papers · 260 · h-index 7

Impact in

    • Immune cells in cancer
    • Phagocytosis and Immune Regulation
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • COVID-19 Clinical Research Studies 5
    • SARS-CoV-2 and COVID-19 Research 4
    • SARS-CoV-2 detection and testing 2
    • Organ Transplantation Techniques and Outcomes 1

SubbaRao V. Tulimilli

11 papers receiving 256 citations

Peers

SubbaRao V. Tulimilli
Comparison fields: 5 of 63
  • Immunology 97
  • Oncology 65
  • Cancer Research 34
  • Infectious Diseases 42
  • Hepatology 15
Replace Pei-Ying Wu with:
Pei-Ying Wu Taiwan
Evgenia Turtoi France
Wenhua You China
Maria I. Edilova Canada
Gerolamo Bevivino Italy
Theodore J. Sanders United Kingdom
Bernard Souberbielle United Kingdom
Sahar Khorasani Iran
Jason T. Henry United States
Peitao Zhou China
SubbaRao V. Tulimilli relative to Pei-Ying Wu Taiwan Pei-Ying Wu's profile →
Citations per field
00.5×1.5×2.5×
Pei-Ying Wu · 1×
Citations per year

Countries citing papers authored by SubbaRao V. Tulimilli

Since Specialization
Citations

This map shows the geographic impact of SubbaRao V. Tulimilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SubbaRao V. Tulimilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SubbaRao V. Tulimilli more than expected).

Fields of papers citing papers by SubbaRao V. Tulimilli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SubbaRao V. Tulimilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SubbaRao V. Tulimilli. The network helps show where SubbaRao V. Tulimilli may publish in the future.

Co-authors

The 23 scholars most cited alongside SubbaRao V. Tulimilli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with SubbaRao V. Tulimilli Line = papers co-authored together SubbaRao V. Tulimilli links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 2021157
2 202322
3 201822
4 202215
5 202112
6 202411
7 20228
8 20225
9 20234
10 20253
11 20261
12 20240

About SubbaRao V. Tulimilli

SubbaRao V. Tulimilli is a scholar working on Infectious Diseases, Surgery, Molecular Biology, Pathology and Forensic Medicine and Neurology, having authored 12 papers that have together received 260 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (2 papers), Long-Term Effects of COVID-19 (2 papers), Diabetes Management and Research (1 paper), Organ Transplantation Techniques and Outcomes (1 paper), Cancer Mechanisms and Therapy (1 paper) and Vitamin C and Antioxidants Research (1 paper). The work is most often cited by research in Immunology (97 citations), Oncology (65 citations), Cancer Research (34 citations), Infectious Diseases (42 citations) and Hepatology (15 citations). SubbaRao V. Tulimilli has collaborated with scholars based in India, Russia and Australia. Frequent co-authors include SubbaRao V. Madhunapantula, Siva Dallavalasa, Narasimha M. Beeraka, Gjumrakch Aliev, Ravindra P. Veeranna, Neha R. Dhoke, Amitava Das, Ramasatyaveni Geesala, Vinay Kumar Rao and Edmund Tse. Their work appears in journals such as Vaccines, Cancers, Current Medicinal Chemistry, BioMed Research International and Canadian Journal of Physiology and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact